Lee Nisley Newcomer

Lee Nisley Newcomer discloses dealings in 2 companies, chiefly Myriad Genetics Inc and Coherus Oncology, Inc. In total, 7 filings cover trades dated from 3 June 2021 to 5 June 2026.

Every open-market trade on record is a sale: 1 sale worth €145k. Besides market trades, the filings include 6 share grants.

Most recently, on 9 June 2026, the filings show a share grant in Coherus Oncology, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.